A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase not reported
- Study design
- RANDOMIZED · PARALLEL · PREVENTION · SINGLE
- Evidence population
- Human clinical study registration
- Participants
- 60
- Population
- ALL · 60 Years to 100 Years
- Duration
- 2024-08-01 to 2025-07-01
- Intervention
- Auditory-cognitive dual-task training (ACDT)
- Comparator
- Control
- Outcomes measured
- Global cognition — will be assessed at baseline (T0), and Week 12 (immediately after the intervention) (T1); Learning and memory — will be assessed at baseline (T0), and Week 12 (immediately after the intervention) (T1); Hearing — will be assessed at baseline (T0), and Week 12 (immediately after the intervention) (T1); Social isolation — will be assessed at baseline (T0), and Week 12 (immediately after the intervention) (T1); Loneliness — will be assessed at baseline (T0), and Week 12 (immediately after the intervention) (T1); Attention or working memory — will be assessed at baseline (T0), and Week 12 (immediately after the intervention) (T1); Information processing speed — will be assessed at baseline (T0), and Week 12 (immediately after the intervention) (T1); Executive function — will be assessed at baseline (T0), and Week 12 (immediately after the intervention) (T1); Verbal fluency — will be assessed at baseline (T0), and Week 12 (immediately after the intervention) (T1); Motor skills — will be assessed at baseline (T0), and Week 12 (immediately after the intervention) (T1)
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Hearing ageing · 100%Abstract contains controlled term: age-related hearing loss. Source terminology contains: age-related hearing loss. Title supplies longevity context: older adult. Study type is explicitly identified as INTERVENTIONAL.
Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.
